GESTIÓN EN SALUD PÚBLICA: Reporting Amount of Listed Drugs and Biological Products Under Section 510(j)(3) of the Federal Food, Drug, and Cosmetic Act; Draft Guidance for Industry | FDA

lunes, 1 de noviembre de 2021

Reporting Amount of Listed Drugs and Biological Products Under Section 510(j)(3) of the Federal Food, Drug, and Cosmetic Act; Draft Guidance for Industry | FDA

Reporting Amount of Listed Drugs and Biological Products Under Section 510(j)(3) of the Federal Food, Drug, and Cosmetic Act; Draft Guidance for Industry | FDA

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)